The anti-HBV activity of HOO-IMM PLUS-B has been reported by many Ayush clinicians in India and pharmacist from Africa. HOO-IMM PLUS has been extensively clinically studied against HBV on the inhibition of HBsAg secretion and also the inhibition of Hepato carcinoma in HepG2 cell line. Clinically patients receiving Hooimm plus reported Target not detected in HBV Quantitative.

This test is highly recommended in Chronic HBV- World Health Organization (WHO)